We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Method to Evaluate the Risk of Aneurysm Rupture

By HospiMedica staff writers
Posted on 13 Feb 2003
Scientists have developed a computer model to predict the rupture potential of an abdominal aortic aneurysm (AAA), which will help surgeons decide when to operate. More...
The method was presented at the 2003 Congress on Abdominal Aortic Aneurysms in Stockholm (Sweden).

Most AAAs are easy to diagnose with an ultrasound test and can usually be treated. The big question for surgeons is when that treatment should take place. Scientists at the University of Pittsburgh's McGowan Institute for Regenerative Medicine (PA, USA; www.mirm.pitt.edu) measured samples of vascular tissue removed during AAA surgical repair and combined it with patient information on smoking, family history, gender, and AAA size. Based on these, they then developed a statistical model to predict the local strength of an aneurysm wall. When this is combined with biomechanical analysis of stresses, a rupture potential index can be calculated with a range from zero to one.

"Until now, all abdominal aortic aneurysms have been treated more or less the same way, in that they are surgically repaired when the maximum diameter reaches a certain size, usually five centimeters,” explained David Vorp, Ph.D., director of the Vascular Biomechanics and Vascular Tissue Engineering Research Laboratories at the McGowan Institute. "We are looking at AAA in a more biomechanical way. Material failure, or a rupture, will occur when the stress at any point exceeds the strength of the material.”





Related Links:
U. Pittsburgh's McGowan Inst.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.